2019
DOI: 10.1016/j.eucr.2019.100913
|View full text |Cite
|
Sign up to set email alerts
|

Paratesticular leiomyosarcoma: A clinical case report

Abstract: We present you a Case of 62 year old man with Paratesticular leiomyosarcoma (LMS) localized to the right sctotal half. Detailed pathological and immunohistochemistry characteristic of the tumor was done. For staging was used the classification of French Federation of Cancer Centres Sarcoma Grading System. The final grading of the tumor is grade 3. Paratesticular LMS is rare identity and serves as a diagnostic and treatment challenge.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
4
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(7 citation statements)
references
References 5 publications
0
4
0
Order By: Relevance
“…Chemotherapy is controversial and has only been used in the case of metastatic disease [ 1 , 4 ]. Although there is limited data about this tumor, some literature mentioned that five- and 10-year disease-specific survival rates are 77% and 66% respectively [ 10 ]. Regardless of this relatively good long-term survival, because recurrences are common, close follow-up is suggested for disease surveillance.…”
Section: Discussionmentioning
confidence: 99%
“…Chemotherapy is controversial and has only been used in the case of metastatic disease [ 1 , 4 ]. Although there is limited data about this tumor, some literature mentioned that five- and 10-year disease-specific survival rates are 77% and 66% respectively [ 10 ]. Regardless of this relatively good long-term survival, because recurrences are common, close follow-up is suggested for disease surveillance.…”
Section: Discussionmentioning
confidence: 99%
“…It has a mesenchymal cell origin and smooth muscle differentiation. There is no evidence for a genetic abnormality in spermatic cord LMS [ 8 ]. The disease-specific survival rate is between 77% [ 8 ].…”
Section: Discussionmentioning
confidence: 99%
“…There is no evidence for a genetic abnormality in spermatic cord LMS [ 8 ]. The disease-specific survival rate is between 77% [ 8 ]. LMS of the spermatic cord is very rare with 113 cases reported to date worldwide [ 9 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Rodriguez D et alreported that tumor grade, stage, histological type, lymph node metastasis, and distant metastasis were independent prognostic indicators of paratesticular leiomyosarcoma (4). Kolev et alproposed that EL recurrence is common; therefore, early diagnosis and differential diagnosis are very important (5).…”
Section: Introductionmentioning
confidence: 99%